Chinese venture capital firm Insight Capital has completed fundraising for its third fund, collecting 500 million yuan ($71.89 million) in capital commitments.
The new fund will continue to seek investment opportunities in the healthcare space in China.
With the completion of the new fund, Insight Capital has nearly $144 million under management.
Limited partners in the new investment vehicle include government guidance funds, founders of pharmaceutical companies and domestic fund-of-funds.